8-Benzyloxy-5-(2-Bromoacetyl) -2-Hydroxyquinoline CAS 100331-89-3 Indacaterol Maleate Faktori Entèmedyè
Pwovizyon komèsyal Indacaterol Maleate (CAS: 753498-25-8) Entèmedyè ki gen rapò:
5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride CAS: 312753-53-0
8-Benzyloxy-5-(2-Bromoacetyl) -2-Hydroxyquinoline CAS: 100331-89-3
5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone CAS: 173140-90-4
Non Chimik | 8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline |
Sinonim | 8-(Benzyloxy)-5-(2-Bromoacetyl)quinolin-2(1H)-yon sèl;5-(Bromoacetyl)-8-(Phenylmethoxy)-2(1H)-Quinolinone;5-(2-Bromo-1-Oxoethyl)-8-Benzyloxy-2(1H)-Quinolinone;5-Bromoacetyl-8-Benzyloxycarbostyril |
Nimewo CAS | 100331-89-3 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C18H14BrNO3 |
Pwa molekilè | 372.21 |
Pwen k ap fonn | 192.0 ~ 194.0 ℃ |
Pwen bouyi | 602.6±55.0℃ nan 760 mmHg |
Dansite | 1.479±0.06 g/cm3 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Off-blan pou jòn poud |
Pite / Metòd analiz | >95.0% (HPLC) |
Imidite (KF) | <1.00% |
Rezid sou ignisyon | <0.50% |
Enpurte A | <3.00% (5-Acetyl-8-(Benzyloxy)quinolin-2(1H)-yon sèl) |
Nenpòt lòt sèl enpurte | <1.50% |
Enpurte total | <5.00% |
Enfrawouj Spectrum | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Indacaterol Maleate (CAS: 753498-25-8) Entèmedyè |
Pake:Boutèy, sache papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an.
Kondisyon Depo:Kenbe veso a byen fèmen epi estoke nan yon depo ki fre, sèk ak byen vantile lwen sibstans ki enkonpatib.Pwoteje kont limyè ak imidite.
Livrezon:Livre nan atravè lemond pa lè, pa FedEx / DHL Express.Bay livrezon rapid ak serye.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan 8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline (CAS: 100331-89-3) ak bon jan kalite segondè, li se yon entèmedyè tipikman nan la. sentèz Indacaterol Maleate (CAS: 753498-25-8).
Indacaterol Maleate (CAS: 753498-25-8) se yon nouvo agonist β (2)-adrenoceptor ak bronchodilator ki aji byen rapid.Yo itilize li nan tretman maladi poumon kwonik obstriktif (COPD) ak opresyon.Ajans Medikaman Ewopeyen an (EMA) te apwouve indacaterol kòm yon dwòg an 2009 sou non komèsyal Onbrez pandan ke nan Etazini Administrasyon Manje ak Medikaman te apwouve li sou non komèsyal Arcapta an 2011. Se dwòg la fabrike kòm fòm maleate sèl li yo.Epitou, indacaterol se yon molekil chiral;sepandan, sèlman pi bon kalite R-enantiomer distribiye.